Medifast, Inc.
MED
$10.53
$0.100.96%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -16.01% | -15.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -16.01% | -15.30% | |||
| Cost of Revenue | -15.76% | -5.75% | |||
| Gross Profit | -16.12% | -18.90% | |||
| SG&A Expenses | -9.51% | -14.97% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.33% | -12.32% | |||
| Operating Income | -91.20% | -282.83% | |||
| Income Before Tax | -140.20% | -192.42% | |||
| Income Tax Expenses | 3,063.89% | -200.25% | |||
| Earnings from Continuing Operations | -701.37% | -191.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -701.37% | -191.17% | |||
| EBIT | -91.20% | -282.83% | |||
| EBITDA | -589.67% | -121.11% | |||
| EPS Basic | -701.41% | -191.18% | |||
| Normalized Basic EPS | -140.17% | -192.42% | |||
| EPS Diluted | -685.00% | -195.45% | |||
| Normalized Diluted EPS | -140.17% | -192.98% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -1.00% | |||